Direct cross-coupling offers a selective route to highly useful 1,2-dihydropyridines
Researchers in the Doyle lab at Princeton have developed a direct cross-coupling reaction to produce nitrogen-containing compounds called 1,2-dihydropyridines, versatile building blocks that are highly useful in pharmaceutical research.
Researchers in the Doyle lab at Princeton have developed a direct and selective cross-coupling reaction that employs a chiral nickel catalyst and an activating agent at low temperatures to couple nucleophilic arenes, common motifs in bioactive compounds, with a feedstock chemical known as pyridine.
Credit: Doyle lab
Published in Chemical Science, the reaction employs a chiral nickel catalyst and an activating agent at low temperatures to couple nucleophilic arenes, common motifs in bioactive compounds, with a feedstock chemical known as pyridine.
"A highlight of the method is being able to use pyridine as a substrate because it's inexpensive and abundant and has rarely been used in transition metal and asymmetric catalysis," said Abigail Doyle, an associate professor of chemistry at Princeton and corresponding author of the article.
Performing transition metal chemistry with pyridine has proven challenging because it can 'poison' the nickel catalyst, essentially binding to the nickel such that the reaction cannot move forward. The research team found that they could overcome this limitation by adding a slight excess of an activating agent, a compound known as iso-butylchloroformate. This addition favors the formation of an intermediate species that will not bind to the catalyst and allows the reaction to proceed.
The method is also highly enantio- and regioselective, meaning that researchers could control the precise geometry and position at which the new chemical bond is formed between the two coupling partners, attractive features that have not been offered by previous methods.
The researchers went a step further by demonstrating the utility of the product by performing nine different elaborations commonly used by medicinal chemists in drug development. "That was my favorite part to do," said Patrick Lutz, a graduate student in the Doyle lab and lead author of the paper. "Optimization is necessary, and exciting when you find ways to improve the reaction, but it was really fun thinking about all the different types of reactions that I could do."
Read the full article here:
Lutz, J. P.; Chau, S. T.; Doyle, A. G. "Nickel-catalyzed enantioselective arylation of pyridine." Chem. Sci. 2016, Advance article.
This work was supported by the National Institutes of Health National Institute of General Medical Sciences (R01 GM100985) and a National Science Foundation Graduate Research Fellowship to J.P.L (DGE-1148900).
Tien Nguyen | EurekAlert!
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering